Beth Resman-Targoff to Humans
This is a "connection" page, showing publications Beth Resman-Targoff has written about Humans.
Connection Strength
0.105
-
Aggressive treatment of early rheumatoid arthritis: recognizing the window of opportunity and treating to target goals. Am J Manag Care. 2010 11; 16(9 Suppl):S249-58.
Score: 0.021
-
Medical therapy: where are we now? Am J Health Syst Pharm. 2006 Sep 15; 63(18 Suppl 4):S11-8.
Score: 0.015
-
Improving rheumatoid arthritis outcomes: how do we get there? Am J Health Syst Pharm. 2006 Sep 15; 63(18 Suppl 4):S42-4.
Score: 0.015
-
Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?. J Pain Palliat Care Pharmacother. 2006; 20(4):11-32.
Score: 0.015
-
Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome. Pharmacotherapy. 1995 Nov-Dec; 15(6):793-7.
Score: 0.007
-
Monoclonal antibodies in the treatment of rheumatoid arthritis. Ann Pharmacother. 1994 May; 28(5):650-4.
Score: 0.007
-
An active-learning strategies primer for achieving ability-based educational outcomes. Am J Pharm Educ. 2011 Nov 10; 75(9):186.
Score: 0.006
-
Ketorolac: a parenteral nonsteroidal antiinflammatory drug. DICP. 1990 Nov; 24(11):1098-104.
Score: 0.005
-
Quality experiential education. Pharmacotherapy. 2008 Dec; 28(12):1547.
Score: 0.005
-
Ensuring quality experiential education. Pharmacotherapy. 2008 Dec; 28(12):1548-51.
Score: 0.005
-
Evolution of clinical pharmacy in the practice of rheumatology. Ann Pharmacother. 2007 Oct; 41(10):1705-7.
Score: 0.004
-
Use of cyclosporine in rheumatoid arthritis. Ann Pharmacother. 1993 Jan; 27(1):44-6.
Score: 0.001